ARCHIVES

FDA Approves Taxotere For Node+ Breast Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

NCI programs: AIDS Malignancy Program gets new director, authority.

November 4, 2005

DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation

November 22, 1991

Wyngaarden Law With Appointment Report; DeVita Tells Congress “We’re Addressing The Issue Internally”

March 20, 1987

In Brief: Reorganization Package Wending Its Way Through The Bureaucracy; FDA Seeks Names for Committee

November 30, 1979

Stanley Reimann: How One Man Saved a Research Institute

October 28, 2021

Two Breast Cancer Program Announcements Listed On Screening, Genetic Susceptibility

February 1, 1980